IART · Integra Lifesciences Holdings Corp · Executive Compensation

$11.99 -0.34 (-2.76%)

S&P 600 member Russell 2000 member Rebalance outlook locked

Market Cap

$958.55M

77.77M

Volume · Oct 23 667.98K Avg daily vol (3M) 956.25K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mojdeh Poul	President and Chief Executive Officer and Director	$1,009,616	$350,438	$5,219,868	$2,250,011	$174,563	$371,056	$9,375,551
Lea Knight	Executive Vice President and Chief Financial Officer	$638,646	$154,897	$1,498,719	$499,574	$77,158	$14,000	$2,882,994
Harvinder Singh	Executive Vice President, President, International	$563,993	$91,194	$683,126	$227,704	$45,426	$14,000	$1,625,444
Jan De Witte	Former President and Chief Executive Officer and Director	$42,308	—	—	—	—	$240,372	$282,679

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jan De Witte	President and Chief Executive Officer and Director	$968,998	—	$4,500,045	$1,500,012	$491,250	$34,363	$7,494,668
Michael McBreen	Executive Vice President, President, Codman Specialty Surgical	$638,702	$222,705	$1,627,799	$442,584	$215,045	$13,455	$3,160,291
Lea Knight	Executive Vice President and Chief Financial Officer	$616,662	$281,942	$1,584,589	$428,189	$220,284	$13,800	$3,145,466
Harvinder Singh	Executive Vice President, President, International	$511,088	$134,310	$1,375,853	$258,610	$129,690	$214,631	$2,624,181
Robert T. Davis	Executive Vice President, President, Tissue Technologies	$544,944	$134,803	$1,203,880	$234,620	$130,167	$13,800	$2,262,214

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jan De Witte	President and Chief Executive Officer and Director	$875,467	—	$4,125,076	$1,375,013	—	$13,200	$6,388,756
Michael McBreen	Executive Vice President, President, Codman Specialty Surgical	$598,077	—	$1,789,174	$429,701	—	$13,200	$2,830,152
Lea Knight	Executive Vice President and Chief Financial Officer	$295,385	$350,000	$1,000,000	—	—	$27,762	$1,673,147
Eric I. Schwartz	Executive Vice President, Chief Legal Officer & Secretary	$536,318	—	$804,100	$268,002	—	$13,200	$1,621,620
Robert T. Davis	Executive Vice President, President, Tissue Technologies	$515,990	—	$670,392	$223,439	—	$13,062	$1,422,883
Jeffrey Mosebrook	Senior Vice President, Finance and Interim PFO	$368,050	$111,888	$760,156	—	—	$13,200	$1,253,294
Carrie Anderson	Former Executive Vice President and Chief Financial Officer	$64,692	—	—	—	—	$2,588	$67,280

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jan De Witte	President and Chief Executive Officer and Director	$850,000	—	$6,500,093	$1,000,014	$813,450	$156,356	$9,319,913
Glenn Coleman	Former Executive Vice President and Chief Operating Officer	$463,500	—	$1,390,554	$463,512	$430,128	$1,677,870	$4,425,564
Eric I. Schwartz	Executive Vice President, Chief Legal Officer & Secretary	$525,000	—	$1,912,606	$637,500	$310,000	$12,200	$3,397,306
Carrie Anderson	Former Executive Vice President and Chief Financial Officer	$565,404	—	$1,968,080	$406,010	—	$12,200	$2,951,694
Michael McBreen	Executive Vice President, President, Codman Specialty Surgical	$494,469	—	$1,150,884	$216,929	$274,100	$12,200	$2,148,582
Robert T. Davis	Executive Vice President, President, Tissue Technologies	$498,030	—	$938,496	$212,809	$271,000	$12,200	$1,932,535

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Arduini	President and Chief Executive Officer and Director	$956,308	—	$5,750,092	$1,500,021	$1,621,200	$11,600	$9,839,221
Glenn Coleman	Former Executive Vice President and Chief Operating Officer	$613,292	—	$1,761,407	$463,502	$688,000	$11,267	$3,537,468
Carrie Anderson	Former Executive Vice President and Chief Financial Officer	$518,462	—	$1,246,979	$328,142	$515,000	$28,081	$2,636,663
Robert T. Davis	Executive Vice President, President, Tissue Technologies	$487,022	—	$875,970	$208,551	$375,000	$11,301	$1,957,844
Michael McBreen	Executive Vice President, President, Codman Specialty Surgical	$459,969	—	$827,483	$197,007	$385,000	$10,908	$1,880,367
Jan De Witte	President and Chief Executive Officer and Director	$58,846	—	—	—	$144,384	$48,543	$251,773
Jan D. De Witte	President and Chief Executive Officer and Director	$58,846	—	—	—	$144,384	$48,543	$251,773

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Arduini	President and Chief Executive Officer and Director	$848,077	—	$4,200,065	$1,800,003	$882,000	$10,554	$7,740,699
Glenn Coleman	Former Executive Vice President and Chief Operating Officer	$559,615	—	$1,330,034	$570,010	$360,000	$8,331	$2,827,990
Carrie Anderson	Former Executive Vice President and Chief Financial Officer	$466,346	—	$875,046	$375,003	$262,500	$81,860	$2,060,755
Robert T. Davis	Executive Vice President, President, Tissue Technologies	$449,600	—	$483,061	$207,008	$214,508	$11,400	$1,365,577
Michael McBreen	Executive Vice President, President, Codman Specialty Surgical	$385,308	—	$547,553	$127,512	$202,500	$11,400	$1,274,273

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Arduini	President and Chief Executive Officer and Director	$975,000	—	$3,990,017	$1,710,006	$1,176,000	$8,400	$7,859,423
Glenn Coleman	Executive Vice President and Chief Operating Officer	$585,426	—	$1,654,286	$387,506	$482,000	$11,200	$3,120,418
Robert T. Davis	Executive Vice President, President, Tissue Technologies	$473,213	—	$453,598	$194,390	$258,000	$11,200	$1,390,401
Daniel L. Reuvers	Executive Vice President, President, Codman Surgical Solutions	$445,250	—	$416,585	$178,517	$290,000	$11,200	$1,341,552

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Arduini	President and Chief Executive Officer and Director	$947,916	—	$3,815,037	$1,635,003	$1,232,640	$17,216	$7,647,812
Glenn Coleman	Executive Vice President and Chief Operating Officer	$556,200	—	$869,428	$372,612	$480,730	$15,700	$2,294,670
Daniel L. Reuvers	Executive Vice President, President, Codman Surgical Solutions	$418,920	—	$892,085	$168,011	$326,000	$13,363	$1,818,379
Robert T. Davis	Executive Vice President, President, Tissue Technologies	$458,350	—	$437,582	$187,504	$272,000	$13,980	$1,369,416
Eric I. Schwartz	Executive Vice President, Chief Legal Officer and Secretary	$57,212	$180,000	$900,008	—	—	—	$1,137,220

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Arduini	President and Chief Executive Officer and Director	$905,024	—	$3,325,053	$1,425,003	$1,463,422	$16,066	$7,134,568
Glenn Coleman	Executive Vice President and Chief Operating Officer	$536,250	—	$805,022	$345,000	$590,000	$10,950	$2,287,222
Robert T. Davis	Executive Vice President, President, Orthopedics and Tissue Technologies	$441,250	—	$437,543	$187,501	$360,000	$8,000	$1,434,294
Daniel L. Reuvers	Executive Vice President, President, Codman Surgical Solutions	$407,258	—	$262,560	$112,514	$375,000	$117,726	$1,275,058

Executive changes

Person	Role	Change	Effective	Filed
Michael McBreen	Chief Commercial Officer	Appointed	2026-05-01	2026-05-05
Mojdeh Poul	member of the Company's Board of Directors	Resigned	2026-04-30	2026-05-05
Dr. Stuart M. Essig	President and Chief Executive Officer	Appointed	2026-05-01	2026-05-05
Stuart M. Essig, Ph.D.	non-executive Chairman of the Board	Appointed	2025-07-01	2025-05-13
Jan De Witte	director	Resigned	2025-01-06	2024-11-04
Jan De Witte	President and Chief Executive Officer	Resigned	2025-01-06	2024-11-04
Mojdeh Poul	director	Appointed	2025-01-06	2024-11-04
Mojdeh Poul	President and Chief Executive Officer	Appointed	2025-01-06	2024-11-04
Christian S. Schade	director	Appointed	2024-05-09	2024-05-13
Renee W. Lo	director	Appointed	2024-05-09	2024-05-13
Raymond G. Murphy	director	Appointed	2024-05-09	2024-05-13
Barbara B. Hill	director	Appointed	2024-05-09	2024-05-13
Stuart M. Essig, Ph.D.	director	Appointed	2024-05-09	2024-05-13
Jeffrey A. Graves, Ph.D.	director	Appointed	2024-05-09	2024-05-13
Shaundra D. Clay	director	Appointed	2024-05-09	2024-05-13
Jan De Witte	director	Appointed	2024-05-09	2024-05-13
Keith Bradley, Ph.D.	director	Appointed	2024-05-09	2024-05-13
Stuart M. Essig	Executive Chairman	Appointed	2024-02-27	2024-02-28
Jan De Witte	director	Retired	—	2024-02-28
Jan De Witte	President and Chief Executive Officer	Retired	—	2024-02-28
Jeff Graves	Board of Directors	Appointed	2023-12-12	2023-12-13
Jeffrey Alan Graves	director	Appointed	2023-12-12	2023-12-13
Lea Daniels Knight	Executive Vice President and Chief Financial Officer	Appointed	2023-06-28	2023-06-21
Carrie Anderson	Chief Financial Officer	Resigned	2023-02-02	2023-01-25
Glenn Coleman	Chief Operating Officer	Terminated	2022-10-03	2022-08-29

Leadership

Dr. Stuart M. Essig CEO
Mojdeh Poul CEO, Board Member
Stuart M. Essig CEO, Chairman
Stuart Essig Chairman
Stuart M. Essig, Ph.D. Chairman, Board Member
Lea Knight CFO
Barbara B. Hill Board Member
Christian S. Schade Board Member
Jan D. De Witte Board Member
Jeff Graves Board Member
Jeffrey A. Graves, Ph.D. Board Member
Jeffrey Alan Graves Board Member
Keith Bradley Board Member
Keith Bradley, Ph.D. Board Member
Raymond G. Murphy Board Member
Renee Lo Board Member
Renee W. Lo Board Member
Renee Wonlai Lo Board Member
Shaundra Clay Board Member
Shaundra D. Clay Board Member

Key facts CIK 917520 CUSIP 457985208 13F (30d) 26 filings 26 filers Visit website Investor relations